Kairos Pharma, Ltd.

KAPA·AMEX·$0.53Share Price as of 11/2·$11MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/12/26 10-QQ1 ended 03/31/2605/13/26 10-KFY 202503/31/26 10-QQ3 ended 09/30/2511/14/25 10-QQ2 ended 06/30/2508/12/25

Disclosures

8-KCurrent report10/06/26 8-KCurrent report09/14/26 8-KCurrent report08/21/26 8-KCurrent report07/22/26 8-KCurrent report07/15/26

Prospectuses and Registrations

424B3Prospectus04/01/26 424B3Prospectus04/01/26 S-3Shelf registration01/13/26 424B3Prospectus08/19/25 424B3Prospectus04/25/25

Proxies

DEFA14AAdditional proxy materials05/26/26 DEF 14ADefinitive proxy05/22/26 PRE 14APreliminary proxy05/11/26 DEFR14ADefinitive proxy (revised)05/16/25 PRER14APreliminary proxy (revised)05/06/25

Ownership

Form 4Insider transaction12/30/25 Form 4Insider transaction12/23/25 Form 4Insider transaction11/26/25 Form 4Insider transaction11/26/25 Form 4Insider transaction11/26/25

Other

ARSAnnual report to shareholders05/22/26 EFFECTRequest for effectiveness01/23/26 CORRESPCorrespondence with the SEC01/21/26 UPLOADLetter from the SEC01/15/26 EFFECTRequest for effectiveness04/24/25